ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 59 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,000 | -18.8% | 63,500 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $16,000 | -11.1% | 63,500 | 0.0% | 0.01% | +16.7% |
| Q1 2022 | $18,000 | -50.0% | 63,500 | 0.0% | 0.01% | -62.5% |
| Q4 2021 | $36,000 | -44.6% | 63,500 | 0.0% | 0.02% | -48.4% |
| Q3 2021 | $65,000 | -31.6% | 63,500 | -7.3% | 0.03% | -29.5% |
| Q2 2021 | $95,000 | -12.0% | 68,500 | +7.9% | 0.04% | -20.0% |
| Q1 2021 | $108,000 | +36.7% | 63,500 | 0.0% | 0.06% | +31.0% |
| Q4 2020 | $79,000 | -12.2% | 63,500 | 0.0% | 0.04% | -30.0% |
| Q3 2020 | $90,000 | +21.6% | 63,500 | +3.3% | 0.06% | +33.3% |
| Q2 2020 | $74,000 | +1.4% | 61,500 | 0.0% | 0.04% | -13.5% |
| Q1 2020 | $73,000 | -43.8% | 61,500 | 0.0% | 0.05% | -3.7% |
| Q4 2019 | $130,000 | +20.4% | 61,500 | +99.0% | 0.05% | +10.2% |
| Q1 2019 | $108,000 | – | 30,900 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 1,652,190 | $3,817,000 | 2.58% |
| LINCOLN CAPITAL CORP | 62,000 | $143,000 | 0.13% |
| Laurion Capital Management LP | 1,944,727 | $4,492,000 | 0.08% |
| Cedar Wealth Management, LLC | 46,395 | $107,000 | 0.08% |
| Fosun International Ltd | 301,708 | $709,000 | 0.04% |
| BCWM, LLC | 35,100 | $811,000 | 0.04% |
| Engineers Gate Manager LP | 170,800 | $395,000 | 0.03% |
| Alpine Global Management, LLC | 45,211 | $104,000 | 0.03% |
| MOORE CAPITAL MANAGEMENT, LP | 250,000 | $578,000 | 0.02% |
| SECTORAL ASSET MANAGEMENT INC | 73,778 | $170,000 | 0.02% |